SCHEMBL4467650

SCHEMBL4467650

C1=CC2(c3ccc(-c4scc5ccccc45)nc3)CCN(C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215870 0.81 KDM1A (0.44)
Bromide SCHEMBL4474316 0.80 KDM1A (0.43)
SCHEMBL4463819 0.79 HSD11B1 (0.38)
SCHEMBL5220054 0.79 HCRTR1 (0.31)
SCHEMBL4463636 0.79
Bromide SCHEMBL4466117 0.78 HSD11B1 (0.37)
Bromide SCHEMBL4469354 0.78 HCRTR1 (0.31)
SCHEMBL4467652 0.78 KDM1A (0.43)
SCHEMBL5217300 0.78 HPGDS (0.37)
SCHEMBL4463632 0.77 CYP11B1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585974-B2 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application SANOFI-AVENTIS (FR) 2009-09-08 US claimed
US-20070185137-A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application SANOFI-AVENTIS (FR) 2007-08-09 US claimed
EP-1465893-B1 DERIVATIVES OF 5-(PYRIDIN-3-YL)-1-AZABICYCLO (3.2.1) OCTANE, THE PREPARATION THEREOF AND THE APPLICATION OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2007-02-28 EP claimed